Encapsulate Pharma is an Australian Pharmaceutical Company focused on the Marketing, Sales and Distribution of Speciality Pharmaceuticals. Encapsulate Pharma is the Official Partner of Merz Therapeutics, a fully owned subsidiary of Merz Pharmaceuticals, in delivering therapies for patients with Movement disorders and Spasticity in the Australian Market. We are committed to providing Physicians and their patients with high quality Botulinum Toxin manufactured by Merz Pharmaceuticals together with the support to deliver this treatment effectively to improve patient outcomes – helping patients achieve their goals.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- encapsulatepharma.com
- Keywords
- Burwood.
Encapsulate Pharma Questions
Encapsulate Pharma's website is encapsulatepharma.com
Encapsulate Pharma's LinkedIn profile is https://www.linkedin.com/company/encapsulate-pharma
Encapsulate Pharma has
2 employees.
View email and phone details for 2
employees at Encapsulate Pharma.
Encapsulate Pharma's industry is
Pharmaceutical Manufacturing
Encapsulate Pharma's top competitors are
Theramex,
Merz Therapeutics,
Babushka's Kefir,
Willach Pharmacy Solutions,
Neurorehabilitation Sunshine Coast,
Encapsulate,
Rethink Industries Ksa,
Mindray Australia,
Willach Australia,
Vitris Glass Fittings.
Encapsulate Pharma's categories are Pharmaceutical Manufacturing
Encapsulate Pharma's founding year is 2020
